Ovarian Carcinoma

Top drugs studied for this disease

CLINICAL_TRIALS withdrawal · 2024-08-21
Clinical Trial Update: Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199
The NCT01445275 trial on the cost of cancer risk management in women at elevated genetic risk for ovarian cancer has been withdrawn.
CLINICAL_TRIALS withdrawal · 2022-04-15
Clinical Trial Update: Secondary Cytoreductive Surgery in Platinum-resistant Recurrent Ovarian Cancers [Phase 2, Phase 3]
Clinical trial evaluating secondary cytoreductive surgery in platinum-resistant recurrent ovarian cancer has been withdrawn.